You are here

  • Home
  • Archive
  • Volume 71, Issue 1
  • Evaluation of abatacept administered subcutaneously in adults with active rheumatoid arthritis: impact of withdrawal and reintroduction on immunogenicity, efficacy and safety (phase Iiib ALLOW study)

Citation Tools

Article menu

Download PDFPDF

Clinical and epidemiological research
Extended report
Evaluation of abatacept administered subcutaneously in adults with active rheumatoid arthritis: impact of withdrawal and reintroduction on immunogenicity, efficacy and safety (phase Iiib ALLOW study)

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Kaine J, Gladstein G, Strusberg I, et al
Evaluation of abatacept administered subcutaneously in adults with active rheumatoid arthritis: impact of withdrawal and reintroduction on immunogenicity, efficacy and safety (phase Iiib ALLOW study)
Annals of the Rheumatic Diseases 2012;71:38-44.